Welcome to our dedicated page for 3M news (Ticker: MMM), a resource for investors and traders seeking the latest updates and insights on 3M stock.
3M Company (NYSE: MMM) delivers cutting-edge materials science solutions across safety, transportation, and consumer markets. This news hub provides investors and industry professionals with centralized access to official corporate developments and market-moving updates.
Track 3M's latest earnings announcements, product innovations, and strategic initiatives through verified press releases and curated analysis. Our repository covers essential updates across all business segments including industrial safety systems, electronic materials advancements, and consumer product developments.
Key content categories include quarterly financial disclosures, manufacturing process innovations, sustainability initiatives, and global market expansions. Each update is presented with contextual clarity to support informed decision-making without speculative commentary.
Bookmark this page for streamlined monitoring of 3M's operational milestones and regulatory filings. Combine our real-time updates with historical performance data to maintain a complete perspective on this diversified industrial innovator.
3M (NYSE: MMM) has received U.S. EPA approval for its TB Quat Disinfectant Ready-to-Use Cleaner, effective against SARS-CoV-2, with 99.9% germ-killing efficacy in just 60 seconds on hard surfaces. This cleaner, now available for consumer use, addresses cleaning needs in high-traffic areas like hospitals and schools. It is designed to cut through grease, control mildew, and has a pleasant lemon scent. Major retailers, including Home Depot and Target, will carry the product, furthering 3M's commitment to home care amid the pandemic.
3M announced findings on the PREVENA™ Incision Management System at the 30th AAHKS Annual Meeting, showcasing its effectiveness in reducing 90-day surgical site complications (SSCs) and readmission rates in patients undergoing revision total knee arthroplasty (TKAs). Data revealed that patients using PREVENA™ Therapy experienced a 75% lower risk of SSCs and a 66% lower risk of readmission compared to standard care. The study, which involved 294 patients, reinforces the device's value in minimizing healthcare burdens.
3M has launched the PREVENA RESTOR AXIO•FORM™ Incision Management System, designed for post-operative management of orthopedic lower extremity surgeries. This system enhances recovery by stabilizing wounds and reducing edema, featuring an extended therapy time of up to 14 days. It is the third addition to the PREVENA RESTOR™ Therapy portfolio, aimed at minimizing hospital stays and improving patient outcomes. The device is now commercially available and addresses the complex needs of surgical incisions, benefiting both patients and healthcare providers.
3M reported its third-quarter 2020 results, highlighting a 4.5% year-on-year sales growth to $8.4 billion. Notable segments include Health Care, which grew 25.5%, and Safety and Industrial, up 6.9%. Despite improvements, Transportation and Electronics experienced a 7.4% decline. Both GAAP and adjusted earnings were $2.43 per share, down 10.7% year-on-year. Operating cash flow reached $2.5 billion, and dividends paid totaled $847 million. Given ongoing uncertainty from COVID-19, 3M refrained from providing full-year guidance.
3M launched the 3M™ Visual Attention Software (VAS) at the Adobe MAX 2020 Creativity Conference, providing graphic designers with a tool that acts like a 'visual spellcheck for design'. This AI-driven plugin for Adobe® Photoshop® analyzes visual content, offering insights on what captures attention quickly. It produces reports such as Heatmap and Gaze Sequence to inform design decisions without costly market research. 3M aims to enhance creativity with data-driven insights, demonstrating its commitment to digital innovation and consumer engagement.
3M Littmann Stethoscopes and Eko have announced a collaboration to launch the 3M Littmann CORE Digital Stethoscope. This innovative device integrates analog and digital auscultation, leveraging Eko's AI and software for enhanced heart murmur detection. Key features include sound amplification, active noise cancellation, and telemedicine software access, improving clinician confidence and patient care. The stethoscope is designed for both in-person and remote consultations, marking a significant advancement in auscultation technology.
3M (NYSE: MMM) announced its third-quarter 2020 earnings conference call scheduled for Tuesday, October 27, 2020, at 8 a.m. CDT. Investors can participate by calling (800) 762-2596 in the U.S. or +1 (212) 231-2916 internationally. The conference call will be webcast live and available for replay on 3M’s Investor Relations website. With $32 billion in sales and 96,000 employees, 3M focuses on solving global challenges through innovation.
3M and Discovery Education announced Anika Chebrolu, a 14-year-old from Frisco, Texas, as the winner of the 2020 3M Young Scientist Challenge. Anika's innovative research utilized in-silico methodologies to identify a molecule that could potentially bind to the SARS-CoV-2 spike protein, suggesting a new avenue for COVID-19 treatment. She will receive a $25,000 prize and recognition as America’s Top Young Scientist. The challenge emphasized the importance of STEM education, particularly during the pandemic, and celebrated young innovators through virtual events.
The 3M State of Science Index (SOSI) 2020 reveals increased trust in science due to COVID-19, with 89% of respondents expressing confidence in scientific endeavors. The survey highlights the importance of sustainable solutions, social justice, and diversity in STEM fields. Despite a rise in pro-science sentiment, a significant portion of the population remains unaware of science's everyday impact. The findings emphasize the need for collaboration between governments and businesses to tackle global challenges, particularly in health and environmental issues.
3M is enhancing global efforts to combat fraud related to its personal protective equipment amid the ongoing pandemic. The company has initiated legal action against profiteers, submitting 19 lawsuits and receiving judicial support in nine cases. Key steps include establishing hotlines to report fraud and collaborating with law enforcement to seize around 3.5 million counterfeit respirators worldwide. Notably, 3M has committed to not raising respirator prices during this crisis and has engaged with major e-marketplaces to eliminate fraudulent listings.